Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria-Jesus Blanco

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
ACS Medicinal Chemistry Letters|April 20, 2023
Enhancing the Visibility of Women in the ACS Division of Medicinal Chemistry (ACS MEDI)Jane Aldrich, Shelley Allen, Erika Araujo, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2016
Discovery of dual positive allosteric modulators (PAMs) of the metabotropic glutamate 2 receptor and CysLT1 antagonists for treating migraine headacheMaria-Jesus Blanco, Dana R Benesh, James A Knobelsdorf, et al.
Bioorganic & Medicinal Chemistry Letters|August 15, 2015
Discovery of selective N-[3-(1-methyl-piperidine-4-carbonyl)-phenyl]-benzamide-based 5-HT₁ F receptor agonists: Evolution from bicyclic to monocyclic coresDeyi Zhang, Maria-Jesus Blanco, Bai-Ping Ying, et al.
ACS Medicinal Chemistry Letters|April 17, 2024
Empowering Voices: Inspiring Women in Medicinal ChemistryMaria-Jesus Blanco, Joanne J Bronson, Erin F DiMauro, et al.
Journal of Medicinal Chemistry|March 8, 2024
Empowering Voices: Inspiring Women in Medicinal ChemistryMaria-Jesus Blanco, Joanne J Bronson, Erin F DiMauro, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2016
Novel bicyclo[3.1.0]hexane analogs as antagonists of metabotropic glutamate 2/3 receptors for the treatment of depressionBruce A Dressman, Eric G Tromiczak, Mark D Chappell, et al.
Journal of Medicinal Chemistry|December 23, 2016
Discovery of (1S,2R,3S,4S,5R,6R)-2-Amino-3-[(3,4-difluorophenyl)sulfanylmethyl]-4-hydroxy-bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Hydrochloride (LY3020371·HCl): A Potent, Metabotropic Glutamate 2/3 Receptor Antagonist with Antidepressant-Like ActivityMark D Chappell, Renhua Li, Stephon C Smith, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
ACS Medicinal Chemistry Letters|April 20, 2023
Enhancing the Visibility of Women in the ACS Division of Medicinal Chemistry (ACS MEDI)Jane Aldrich, Shelley Allen, Erika Araujo, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2016
Discovery of dual positive allosteric modulators (PAMs) of the metabotropic glutamate 2 receptor and CysLT1 antagonists for treating migraine headacheMaria-Jesus Blanco, Dana R Benesh, James A Knobelsdorf, et al.
Bioorganic & Medicinal Chemistry Letters|August 15, 2015
Discovery of selective N-[3-(1-methyl-piperidine-4-carbonyl)-phenyl]-benzamide-based 5-HT₁ F receptor agonists: Evolution from bicyclic to monocyclic coresDeyi Zhang, Maria-Jesus Blanco, Bai-Ping Ying, et al.
ACS Medicinal Chemistry Letters|April 17, 2024
Empowering Voices: Inspiring Women in Medicinal ChemistryMaria-Jesus Blanco, Joanne J Bronson, Erin F DiMauro, et al.
Journal of Medicinal Chemistry|March 8, 2024
Empowering Voices: Inspiring Women in Medicinal ChemistryMaria-Jesus Blanco, Joanne J Bronson, Erin F DiMauro, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2016
Novel bicyclo[3.1.0]hexane analogs as antagonists of metabotropic glutamate 2/3 receptors for the treatment of depressionBruce A Dressman, Eric G Tromiczak, Mark D Chappell, et al.
Journal of Medicinal Chemistry|December 23, 2016
Discovery of (1S,2R,3S,4S,5R,6R)-2-Amino-3-[(3,4-difluorophenyl)sulfanylmethyl]-4-hydroxy-bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Hydrochloride (LY3020371·HCl): A Potent, Metabotropic Glutamate 2/3 Receptor Antagonist with Antidepressant-Like ActivityMark D Chappell, Renhua Li, Stephon C Smith, et al.
Pageof 4